Is It Possible to Regenerate the Underactive Detrusor? Part 1. Molecular and Stem Cell Therapies Targeting the Urinary Bladder and Neural Axis ‐ ICI‐RS 2024
Neurourology and Urodynamics · 2025
DOI: 10.1002/nau.25597 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neurourology and Urodynamics, 2025. Verfasst von Sanjay Sinha und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Apollo Hospital, Hyderabad, India. Hauptthemen laut MEDLINE: Urinary Bladder, Urinary Bladder, Underactive, Stem Cell Transplantation, Regeneration. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Introduction
Detrusor muscle weakness is commonly noted on urodynamics in patients with refractory voiding difficulty. No approved therapies have been proven to augment the strength of a detrusor voiding contraction.
Methods
This subject was discussed by a think‐tank at the International Consultation on Incontinence‐ Research Society (ICI‐RS) meeting held in Bristol, June 2024. The discussions of the think‐tank are being published in two parts. This first part discusses molecular and stem cell therapies targeting the urinary bladder and the neural axis.
Results
Senescence of the urothelium and extracellular ATP acting through P2X3 receptors might be important in detrusor underactivity. Several molecules such as parasympathomimetics, acotiamide, ASP8302, neurokinin‐2 agonists have been explored but none has shown unequivocal clinical benefit. Different stem cell therapy approaches have been used, chiefly in neurogenic dysfunction, with some studies showing benefit. Molecular targets for the neural axis have included TRPV‐4, Bombesin, and serotoninergic receptors and TAC‐302 which induces neurite growth.
Conclusions
Several options are currently being pursued in the search for an elusive molecular or stem cell option for enhancing the power of the detrusor muscle. These encompass a wide range of approaches that target each aspect of the contraction mechanism including the urothelium of bladder and urethra, myocyte, and neural pathways. While none of these have shown unequivocal clinical utility, some appear promising. Lessons from other fields of medicine might prove instructive. Clinical Trial Registration Not necessary. Not a clinical trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Apollo Hospital, Hyderabad, India.
- Departamento de Urologia, Hospital de S. João, Faculdade de Medicina do Porto, Porto, Portugal.
- Department of Urology, La Fe University and Polytechnic Hospital, Valencia, Spain.
- Department of Urology, Jagiellonian University, Krakow, Poland.
- Department of Urology, Ghent University, Ghent, Belgium.
- Department of Medicine and Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Sinha, S., Cruz, F., Cuenca, E. M., Przydacz, M., Kheir, G. B., Kanai, A. J., Van Huele, A., Gajewski, J. B., Tarcan, T., Lazar, J. M., Weiss, J. P., Tyagi, P., Abrams, P., & Wein, A. (2025). Is It Possible to Regenerate the Underactive Detrusor? Part 1. Molecular and Stem Cell Therapies Targeting the Urinary Bladder and Neural Axis ‐ ICI‐RS 2024. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25597
Vancouver
Sinha S, Cruz F, Cuenca EM, Przydacz M, Kheir GB, Kanai AJ, et al. Is It Possible to Regenerate the Underactive Detrusor? Part 1. Molecular and Stem Cell Therapies Targeting the Urinary Bladder and Neural Axis ‐ ICI‐RS 2024. Neurourology and Urodynamics. 2025. doi:10.1002/nau.25597
BibTeX
@article{Sinha2025,
author = {Sinha, Sanjay and Cruz, Francisco and Cuenca, Esther Martinez and Przydacz, Mikolaj and Kheir, George Bou and Kanai, Anthony J and Van Huele, Andries and Gajewski, Jerzy B and Tarcan, Tufan and Lazar, Jason M and Weiss, Jeffrey P and Tyagi, Pradeep and Abrams, Paul and Wein, Alan},
title = {Is It Possible to Regenerate the Underactive Detrusor? Part 1. Molecular and Stem Cell Therapies Targeting the Urinary Bladder and Neural Axis ‐ ICI‐RS 2024},
journal = {Neurourology and Urodynamics},
year = {2025},
doi = {10.1002/nau.25597}
}
EUVIMED